Core Viewpoint - The company, Hangzhou Tianmu Mountain Pharmaceutical Co., Ltd., has decided to abolish its supervisory board and amend its articles of association to enhance corporate governance and compliance with relevant laws and regulations [2][3]. Summary by Sections Abolishment of Supervisory Board - The company plans to eliminate the supervisory board, transferring its powers to the audit committee of the board of directors. The relevant rules associated with the supervisory board will also be abolished [2][3]. - The current supervisory board members, including the chairman Liu Desheng and member Wang Lu, will be relieved of their duties. The employee supervisor will also step down after following the necessary procedures [2][3]. Amendment of Articles of Association - The company intends to revise its articles of association to align with the latest legal requirements and its operational needs. The specific amendments will be detailed in an attachment [3][4]. - The proposed changes to the articles of association will require approval from the shareholders' meeting before implementation [3][4]. Governance System Revisions - The company will revise and establish several governance systems to comply with the latest laws and regulations, including rules for shareholder meetings, board meetings, and management of related party transactions [6][7]. - The proposed revisions have been approved by the board of directors and will also need to be ratified by the shareholders' meeting to take effect [6][7]. Disclosure of Revised Articles - The full text of the revised articles of association will be disclosed on the Shanghai Stock Exchange website on August 28, 2025 [3][7].
天目药业: 杭州天目山药业股份有限公司关于取消监事会并修订《公司章程》及制定和修订部分管理制度的公告